The most important wearable health inventions in history did not simply measure the human body. They changed human capability. Eyeglasses restored sight. Hearing aids restored communication. Glucose monitoring enabled metabolic control.

bioverà introduces a new category: active respiratory intelligence.

By placing an intelligent wearable at the nasal pathway, bioverà detects breathing irregularities and actively intervenes in real time using precisely tuned mechanical vibration and localized electromagnetic stimulation. This transforms breathing from a passive signal into a controllable physiological function.

Unlike watches, rings, and trackers that observe and notify, bioverà actively supports respiration at the point where airflow, neurology, and physiology converge.

bioverà transforms breathing from a passive health signal into an actively supported physiological function.

For informational purposes only. Under development. Not a medical claim.

bioverà introduces a patent-pending respiratory intelligence platform designed to sense breathing in real time and provide gentle, non-invasive support for stable airflow.

The core module, Upstream, is a compact nasal device that detects irregularities such as snoring, airflow dips, or early apnea events. It remains completely passive during normal breathing and activates only when needed, preserving natural sleep, comfort, and daily usability.

A microphone and pressure sensor positioned at the nasal bridge continuously capture breath patterns. A low-power embedded processor performs all sensing, analysis, and decision-making on-device, without reliance on external hardware.

When airflow instability is detected, the system delivers precisely tuned, low-intensity responses designed to restore calm nasal breathing:

• 30–40 Hz vibrotactile pulses via miniature coin motors
• 12–18 dB bone-conduction audio cues
• Optional low-energy electromagnetic stimulation (configuration-dependent)

These interventions are designed to guide breathing back to a calm, open nasal state without arousal or sleep disruption.

Upstream personalizes its responses over time by learning individual breathing patterns and trends across nights. Interventions escalate only if instability persists. For significantly abnormal patterns, the system can issue alerts and optional emergency notifications to designated contacts when configured.

An integrated rechargeable lithium battery is designed for full-night runtime, supporting continuous overnight operation in a compact, non-mask form factor.

The gentle stimulation approach behind Upstream is grounded in peer-reviewed research on non-arousing respiratory interventions.

2023 Thorax meta-analysis
Vibrotactile positional therapy devices reduced apnea events by approximately 43 percent, with arousal index unchanged or lower.

2017 SNORAP pilot study
Low-intensity haptic and audio feedback reduced snoring and apnea severity by approximately 51 percent with zero EEG-measured arousals.

bioverà is designed to operate within the same frequency and stimulus ranges shown to be effective in these studies, acting earlier and more precisely at the nasal pathway.

Hardware matching this description is fully functional in-lab. Preliminary overnight trials with real users demonstrate:

• Near-complete detection of snoring and airflow instability
• No user-reported awakenings during testing
• Consistent battery performance exceeding 8 hours

These early results demonstrate technical feasibility and readiness for co-development.

bioverà is not intended to replace CPAP or other established respiratory therapies. Instead, it expands the respiratory care ecosystem by addressing early airflow instability, snoring, and mild-to-moderate events through a passive, non-mask approach.

For partners, Upstream represents a new upstream intervention layer that can improve patient comfort and compliance, extend market reach to underserved populations, and enable data-driven respiratory insights, while integrating seamlessly into existing respiratory and sleep platforms.